Tweet from EricTopol at December 03, 2022 at 08:10AM
Cancer is a genomic disease and there has been extraordinary progress defining mutations that guide optimal therapy. But most patients are still not deriving the benefit of molecular markers or tumor sequencing
https://t.co/nYzGJaTsls @NEJM today @rschilsky https://t.co/S6w4ZELggW— Eric Topol (@EricTopol)
Dec 3, 2022
from http://twitter.com/EricTopol